tiprankstipranks
Hoth Therapeutics Inc (HOTH)
NASDAQ:HOTH
US Market
Holding HOTH?
Track your performance easily

Hoth Therapeutics (HOTH) Income Statement

309 Followers

Hoth Therapeutics Income Statement

Last quarter (Q ), Hoth Therapeutics's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Hoth Therapeutics's net income was $-2.13M. See Hoth Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 1.24B-$ 28.00K-$ 31.15K$ 6.95K
Cost of Revenue
$ 30.00K---$ -10.00K-
Gross Profit
$ 1.23B-$ 28.00K-$ 41.15K$ 6.95K
Operating Expense
$ 3.82M$ 7.69M$ 11.07M$ 14.10M$ 7.30M$ 7.71M
Operating Income
$ -7.93M$ -7.69M$ -11.07M$ -14.10M$ -7.30M$ -7.71M
Net Non Operating Interest Income Expense
-$ 781.00$ 6.37K$ 22.40M--
Other Income Expense
$ -13.77K$ 204.92K$ 312.77K$ 212.26K$ -104.16K$ -10.64K
Pretax Income
$ -3.18M$ -7.85M$ -5.89M$ -7.80M$ -3.02M$ -7.70M
Tax Provision
--$ 1.50M$ -548.66K$ -1.49M$ -1.69M
Earnings From Equity Interest Net Of Tax
--$ -377.00K---
Net Income Common Stockholders
$ -7.89M$ -7.85M$ -11.37M$ -14.31M$ -3.02M$ -7.70M
Basic EPS
$ -1.61$ -2.30$ -9.50$ -16.00--
Diluted EPS
$ -1.61$ -2.30$ -8.79$ -16.00$ -14.50$ -21.00
Basic Average Shares
$ 21.66M$ 3.41M$ 1.20M$ 893.20K$ 494.51K$ 366.58K
Diluted Average Shares
$ 21.66M$ 3.41M$ 1.20M-$ 494.51K$ 366.58K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 3.85M$ 7.69M$ 11.07M$ 14.10M$ 7.29M$ 7.71M
Net Income From Continuing And Discontinued Operation
$ -7.89M$ -7.85M$ -11.37M$ -14.31M$ -7.20M$ -7.70M
Normalized Income
$ -2.87M-$ -4.31M$ -8.41M--
Interest Expense
------
EBIT
$ -3.79M$ -7.85M$ -5.89M$ -14.10M$ -7.30M$ -7.70M
EBITDA
$ -3.79M$ -7.85M$ -5.89M$ -14.10M$ -7.30M$ -7.70M
Currency in USD

Hoth Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis